Goodbye, Status Quo: Reimagining the Landscape of Innovation

In Goodbye, Status Quo, visionary scientist and leading entrepreneur Dr. Joan Fallon equips readers with the tools to overcome obstacles and become agents of change—as entrepreneurs, leaders, and individuals.

In Goodbye, Status Quo, Dr. Joan Fallon equips her readers with the tools to be agents of change: as entrepreneurs, leaders, and individuals. No matter where you come from or who you are, you can be an agent of change. If you are setting out to change the world—great, she affirms—just keep in mind that change must start with you.

As a company founder, Dr. Fallon faced many obstacles. Some of the greatest ones came from how other people saw her. A woman in her fifties with a warm, approachable manner, she didn’t fit the typical entrepreneur profile. Now as a respected business leader, doctor, and academic who sits on the boards of numerous non-profits and is frequently asked to mentor others, Joan is driven to share what she has learned and the perspectives that brought her success.

She is also fascinated by the subject of change. What are the impediments that keep leaders and individuals from changing the world, or even just changing themselves, and how can they be overcome? What is it about you that holds you, your job, or your company back from changing?

Joan Fallon believes that deductive reasoning in addition to the typical inductive reasoning and other science-based approaches allow us to move past the reactive responses that leave us stuck, unable to innovate and make change. Fear-based thinking rules in many sectors today—in business, politics, even relationships. And fear is the fundamental factor that holds us back from embracing change.

Goodbye, Status Quo blends lessons from Joan’s own entrepreneurial experiences and scientific observations to give readers informative and actionable advice on the topics of

entrepreneurship, innovation, and making change. Each chapter offers pithy advice that taps into business, medicine, philosophy, and even baseball.

No matter your background, experience, or personal struggles, you can change the world—if you are willing to first change yourself. 

Dr. Joan Fallon, Founder and CEO of Curemark, is considered a visionary scientist who has dedicated her life’s work to championing the health and wellbeing of children worldwide. Curemark is a biopharmaceutical company focused on the development of novel therapies to treat serious diseases for which there are limited treatment options. The company’s pipeline includes a phase III clinical-stage research program for Autism, as well as programs focused on Parkinson’s Disease, schizophrenia, and addiction.

Curemark will commence the filing of a Biological Drug Application for the first novel drug for Autism under the FDA Fast Track Program. Fast Track status is a designation given only to investigational new drugs that are intended to treat serious or life-threatening conditions and that have demonstrated the potential to address unmet medical needs.

Joan holds over 300 patents worldwide, has written numerous scholarly articles, and lectured extensively across the globe on pediatric developmental problems. A former adjunct assistant professor at Yeshiva University in the Department of Natural Sciences and Mathematics. She holds appointments as a senior advisor to the Henry Crown Fellows at The Aspen Institute, as well as a Distinguished Fellow at the Athena Center for Leadership Studies at Barnard College.

She is also a member of the Board of Trustees of Franklin & Marshall College and The Pratt Institute. She currently serves as a board member at the DREAM Charter School in Harlem, the PitCCh In Foundation started by CC and Amber Sabathia, Springboard Enterprises an internationally known venture catalyst that supports women–led growth companies and Vote Run Lead, a bipartisan not-for-profit that encourages women on both sides of the aisle to run for elected office.

She served on the ADA Board of Advisors for the building of the new Yankee Stadium and has testified before Congress on the matters of business and patents and the lack of diverse patent holders.

Joan is the recipient of numerous awards including being named one of the top 100 Most Intriguing Entrepreneurs of 2020 by Goldman Sachs, 2017 EY Entrepreneur of the Year NY in Healthcare and received the Creative Entrepreneurship Award from The New York Hall of Science in 2018.